https://transportal.compbio.ucsf.edu/compounds/ranolazine/
Ranolazine
Transporter information for Ranolazine.
ranolazine
https://dailymed.nlm.nih.gov/dailymed/medguide.cfm?setid=e2a8c9f9-5f6a-4496-8fd6-2439e564db4f
These highlights do not include all the information needed to use RANOLAZINE EXTENDED-RELEASE...
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8bfd1a61-547a-4847-ae4e-480b17da6272&type=display
These highlights do not include all the information needed to use RANOLAZINE EXTENDED-RELEASE...
https://open.library.emory.edu/concern/publications/1e07aea4-8498-4a46-a99f-b11558006a8b
Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left...
Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized...
prevention and treatment
https://adisinsight.springer.com/trials/700195414?error=cookies_not_supported&code=0f1b7327-bb9f-402e-a6e0-fc573fbd8ef9
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study - AdisInsight
This trial will investigate the effects of ranolazine in patients from various ethnic backgrounds with coronary artery disease and risk factors for metabolic
and themetabolic syndromeranolazineethnicityrems
https://blogs.bmj.com/heart/2016/02/02/ranolazine-ineffective-as-antianginal-following-incomplete-revascularization/
Ranolazine ineffective as antianginal following incomplete revascularization - Heart
Feb 2, 2016 - Ranolazine is a novel anti-anginal medication that operates via late sodium channel blockade, reducing intracellular calcium during ischemia. Prior studies...
ranolazineineffectiveantianginalfollowingincomplete
https://www.cochrane.org/evidence/CD011747_ranolazine-people-stable-angina-pectoris
Ranolazine for people with stable angina pectoris | Cochrane
for peoplestable anginaranolazinecochrane